Scinovex
articleTop 1% cited

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

Bone · 2003 · Vol. 33(4) · pp. 522–532
P. D. DelmasHarry K. GenantGerald CransJohn L. StockM. WongEthel S. SirisJonathan D. Adachi
Bone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatmentsMedicineRaloxifeneOsteoporosisPlaceboSurgeryInternal medicinePathology

MeSH terms

AgedFemaleHumansMiddle AgedRecurrenceRisk FactorsBone DensityOsteoporosis, PostmenopausalSpinal FracturesRaloxifene HydrochlorideFractures, Bone

Funding

  • Eli Lilly and Company
Citations
539
FWCI
24.40
field-weighted impact
References
43
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.